Ontrak (OTRK) Competitors $0.07 -0.01 (-15.29%) As of 03:18 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock OTRK vs. NIVF, BACK, BTTX, UPHL, OPGN, ACONW, AONC, DHACW, FMS, and LFMDPShould you be buying Ontrak stock or one of its competitors? The main competitors of Ontrak include NewGenIvf Group (NIVF), IMAC (BACK), Better Therapeutics (BTTX), UpHealth (UPHL), OpGen (OPGN), Aclarion (ACONW), American Oncology Network (AONC), Digital Health Acquisition (DHACW), Fresenius Medical Care AG & Co. KGaA (FMS), and LifeMD (LFMDP). These companies are all part of the "healthcare" industry. Ontrak vs. Its Competitors NewGenIvf Group IMAC Better Therapeutics UpHealth OpGen Aclarion American Oncology Network Digital Health Acquisition Fresenius Medical Care AG & Co. KGaA LifeMD Ontrak (NASDAQ:OTRK) and NewGenIvf Group (NASDAQ:NIVF) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, risk, profitability, institutional ownership, media sentiment, valuation and earnings. Which has more risk and volatility, OTRK or NIVF? Ontrak has a beta of 1.97, indicating that its stock price is 97% more volatile than the S&P 500. Comparatively, NewGenIvf Group has a beta of -0.09, indicating that its stock price is 109% less volatile than the S&P 500. Does the media refer more to OTRK or NIVF? In the previous week, Ontrak and Ontrak both had 1 articles in the media. Ontrak's average media sentiment score of 1.88 equaled NewGenIvf Group'saverage media sentiment score. Company Overall Sentiment Ontrak Very Positive NewGenIvf Group Very Positive Which has stronger earnings & valuation, OTRK or NIVF? NewGenIvf Group has lower revenue, but higher earnings than Ontrak. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOntrak$10.18M0.03-$25.49M-$15.810.00NewGenIvf Group$5.43M0.30-$520KN/AN/A Is OTRK or NIVF more profitable? NewGenIvf Group has a net margin of 0.00% compared to Ontrak's net margin of -274.20%. NewGenIvf Group's return on equity of 0.00% beat Ontrak's return on equity.Company Net Margins Return on Equity Return on Assets Ontrak-274.20% -269.88% -128.35% NewGenIvf Group N/A N/A N/A Do institutionals & insiders hold more shares of OTRK or NIVF? 12.9% of Ontrak shares are owned by institutional investors. Comparatively, 66.2% of NewGenIvf Group shares are owned by institutional investors. 1.9% of Ontrak shares are owned by company insiders. Comparatively, 31.8% of NewGenIvf Group shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Do analysts rate OTRK or NIVF? Ontrak presently has a consensus price target of $3.00, suggesting a potential upside of 4,066.67%. Given Ontrak's stronger consensus rating and higher probable upside, research analysts clearly believe Ontrak is more favorable than NewGenIvf Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ontrak 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00NewGenIvf Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 SummaryNewGenIvf Group beats Ontrak on 7 of the 12 factors compared between the two stocks. Get Ontrak News Delivered to You Automatically Sign up to receive the latest news and ratings for OTRK and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding OTRK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OTRK vs. The Competition Export to ExcelMetricOntrakMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$304K$4.13B$5.76B$9.75BDividend YieldN/A1.26%3.95%4.02%P/E Ratio0.0028.8731.4526.36Price / Sales0.03168.47431.04155.09Price / CashN/A27.1437.7559.42Price / Book0.032.9010.536.57Net Income-$25.49M$189.47M$3.28B$265.92M7 Day PerformanceN/A-0.32%0.37%0.06%1 Month PerformanceN/A16.24%5.15%1.99%1 Year PerformanceN/A14.55%50.24%20.91% Ontrak Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OTRKOntrak2.7169 of 5 stars$0.07-15.3%$3.00+4,066.7%-97.3%$304K$10.18M0.00250Gap DownNIVFNewGenIvf GroupN/A$1.80+2.9%N/A-99.8%$1.51M$5.43M0.00N/APositive NewsBACKIMACN/A$0.08+12.5%N/A-95.9%$168K$72.05K0.00180BTTXBetter TherapeuticsN/A$0.00flatN/AN/A$5KN/A0.0040UPHLUpHealthN/A$0.00flatN/A-99.9%$4K$130M0.001,750OPGNOpGenN/A$0.00flatN/AN/A$1K$2.67M0.00100ACONWAclarionN/A$0.04-22.1%N/A-6.7%$0.00$62.95K0.007Gap UpAONCAmerican Oncology NetworkN/A$11.11-6.6%N/A+182.3%$0.00$1.34B0.001,520High Trading VolumeDHACWDigital Health AcquisitionN/A$0.03-11.7%N/AN/A$0.00N/A0.00N/AGap DownFMSFresenius Medical Care AG & Co. KGaA3.0362 of 5 stars$25.31-1.1%$27.80+9.8%+29.5%$0.00$20.63B20.751,384Analyst RevisionLFMDPLifeMDN/A$23.70-1.3%N/A+9.5%$0.00$245.56M0.00230 Related Companies and Tools Related Companies NIVF Competitors BACK Competitors BTTX Competitors UPHL Competitors OPGN Competitors ACONW Competitors AONC Competitors DHACW Competitors FMS Competitors LFMDP Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:OTRK) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ontrak, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ontrak With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access